Investigators developed and validated new PSMA-PET-based nomograms for prognostication across prostate cancer stages to help guide management.
The study published by Bastiaan M Privé and colleagues in The Lancet Oncology represents, to our knowledge, the first randomised phase 2 trial evaluating lutetium-177–PSMA-617 (177Lu-PSMA-617) in ...
Dr. Babar Rao highlights clinically meaningful outcomes with majority of lesions potentially avoiding immediate surgery in non-melanoma Skin Cancer PHILADELPHIA, March 30, 2026 (GLOBE NEWSWIRE)-- ...
Q4 2025 Earnings Call March 30, 2026 4:30 PM EDTCompany ParticipantsDaniel Carlson - Head of Investor RelationsDavid Moss ...
Whether you're going in for checkups or common tests, here's how to get the most out of your next visit. The post 10 Things ...